Cost-effectiveness of anidulafungin in confirmed candidaemia and other invasive Candida infections in Spain
Author:
Publisher
Elsevier BV
Subject
Infectious Diseases
Reference62 articles.
1. Guidelines for the treatment of invasive candidiasis and other yeasts. Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2010 Update;Aguado;Enferm Infecc Microbiol Clin,2011
2. Economic impact of caspofungin as compared with liposomal amphotericin B for empirical therapy in febrile neutropenia in Australia;Al-Badriyeh;J Antimicrob Chemother,2009
3. Attributable hospital cost and antifungal treatment of invasive fungal diseases in high-risk hematology patients: an economic modeling approach;Ananda-Rajah;Antimicrob Agents Chemother,2011
4. Invasive Candida species infection: the importance of adequate empirical antifungal therapy;Armstrong-James;J Antimicrob Chemother,2007
5. Recomendaciones de tratamiento antifúngico en pacientes con bajo grado de inmunodepresión;Barberán;Rev Esp Quimioter,2008
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Health-economic modelling of cost savings due to the use of rezafungin based on a German cost-of-illness study of candidiasis;JAC-Antimicrobial Resistance;2023-05-03
2. Cost Effectiveness of Candida Polymerase Chain Reaction Detection and Empirical Antifungal Treatment among Patients with Suspected Fungal Peritonitis in the Intensive Care Unit;Value in Health;2017-12
3. Pharmacoeconomic evaluation of micafungin versus caspofungin as definitive therapy for candidaemia and invasive candidiasis (IC) in Turkey;European Journal of Clinical Microbiology & Infectious Diseases;2017-11-28
4. Cost-effectiveness analysis of anidulafungin vs fluconazole for the treatment of invasive candidiasis (IC) in Turkey;Mycoses;2017-07-12
5. Pharmacoeconomic analysis of antifungal therapy for primary treatment of invasive candidiasis caused by Candida albicans and non-albicans Candida species;BMC Infectious Diseases;2017-07-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3